Atlas Venture Life Science Advisors, LLC Q3 2022 Filing
Filed November 9, 2022
Portfolio Value
$906.2B
Holdings
17
Report Date
Q3 2022
Filing Type
13F-HR
All Holdings (17 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | THRDThird Harmonic Bio, Inc. | 10,907,859 | $206.9B | 22.83% | |
| 2 | DAWNDay One Biopharmaceuticals, Inc. | 8,169,171 | $163.6B | 18.06% | |
| 3 | KYMRKymera Therapeutics, Inc. | 6,875,698 | $149.7B | 16.52% | |
| 4 | DYNDyne Therapeutics, Inc. | 8,934,902 | $113.5B | 12.52% | |
| 5 | REPLReplimune Group, Inc. | 3,108,300 | $53.7B | 5.92% | |
| 6 | VIGLVigil Neuroscience, Inc. | 5,836,874 | $53.1B | 5.86% | |
| 7 | GBIOGBXGeneration Bio, Co. | 8,278,876 | $44.0B | 4.85% | |
| 8 | AVTEAerovate Therapeutics, Inc. | 2,327,909 | $38.6B | 4.26% | |
| 9 | AKROAkero Therapeutics, Inc. | 994,251 | $33.9B | 3.74% | |
| 10 | —Ikena Oncology, Inc. | 5,018,178 | $17.8B | 1.97% | |
| 11 | —Gemini Therapeutics, Inc. | 5,254,365 | $8.6B | 0.95% | |
| 12 | XLOXilio Therapeutics, Inc. | 2,759,344 | $8.0B | 0.89% | |
| 13 | —Magenta Therapeutics, Inc. | 3,476,536 | $4.9B | 0.54% | |
| 14 | —F-star Therapeutics, Inc. | 599,524 | $3.1B | 0.34% | |
| 15 | —AvroBio, Inc. | 4,520,863 | $2.9B | 0.32% | |
| 16 | SPROSpero Therapeutics, Inc. | 1,031,160 | $2.1B | 0.23% | |
| 17 | VRDNViridian Therapeutics, Inc. | 90,072 | $1.8B | 0.20% |